(SON) Sonoco Products - Overview
Stock: Packaging, Containers, Tubes, Paperboard, Cores
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.79% |
| Yield on Cost 5y | 4.19% |
| Yield CAGR 5y | 4.05% |
| Payout Consistency | 77.3% |
| Payout Ratio | 45.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.2% |
| Relative Tail Risk | -2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | 0.34 |
| Character TTM | |
|---|---|
| Beta | 0.640 |
| Beta Downside | 0.524 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.46% |
| CAGR/Max DD | -0.03 |
Description: SON Sonoco Products January 08, 2026
Sonoco Products Company (NYSE: SON) designs, develops, manufactures and sells engineered and sustainable packaging across North America, Europe and Asia-Pacific, operating through two segments: Consumer Packaging (rigid paper, steel and plastic containers, metal closures) and Industrial Paper Packaging (paperboard tubes, cores, protective paper products and recycled paperboard). The firm serves diverse end-markets-including food, textile, construction, wire-cable and film-leveraging a broad material portfolio of plastic, paper, foam and specialty substrates. Founded in 1899, Sonoco is headquartered in Hartsville, South Carolina.
**Key data points (as of Q3 2024 filing):** Revenue of $3.6 billion, up ~4 % YoY, driven by strong e-commerce packaging demand; adjusted EBITDA margin of 11.2 % (down 0.5 pp versus FY 2023, reflecting higher resin and pulp costs); free cash flow of $210 million, supporting a 45 % payout ratio. **Economic drivers** include volatile raw-material prices (cellulose pulp, virgin resin) and freight inflation, while **sector trends** such as regulatory pressure for recyclable packaging and corporate sustainability commitments are expanding the addressable market for Sonoco’s recycled-paper and bio-based solutions.
For a deeper, data-rich assessment of SON’s valuation dynamics, you may find it useful to explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 627.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.04 > 1.0 |
| NWC/Revenue: -4.31% < 20% (prev 36.69%; Δ -41.00% < -1%) |
| CFO/TA 0.06 > 3% & CFO 673.1m > Net Income 627.8m |
| Net Debt (5.16b) to EBITDA (817.2m): 6.31 < 3 |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.6m) vs 12m ago 0.38% < -2% |
| Gross Margin: 21.46% > 18% (prev 0.21%; Δ 2124 % > 0.5%) |
| Asset Turnover: 58.96% > 50% (prev 69.05%; Δ -10.09% > 0%) |
| Interest Coverage Ratio: 1.43 > 6 (EBITDA TTM 817.2m / Interest Expense TTM 231.8m) |
Altman Z'' 1.32
| A: -0.02 (Total Current Assets 3.16b - Total Current Liabilities 3.42b) / Total Assets 11.72b |
| B: 0.26 (Retained Earnings 3.10b / Total Assets 11.72b) |
| C: 0.03 (EBIT TTM 330.4m / Avg Total Assets 10.38b) |
| D: 0.37 (Book Value of Equity 3.11b / Total Liabilities 8.40b) |
| Altman-Z'' Score: 1.32 = BB |
Beneish M -2.64
| DSRI: 1.14 (Receivables 1.29b/1.15b, Revenue 6.12b/6.24b) |
| GMI: 0.99 (GM 21.46% / 21.25%) |
| AQI: 1.50 (AQ_t 0.47 / AQ_t-1 0.31) |
| SGI: 0.98 (Revenue 6.12b / 6.24b) |
| TATA: -0.00 (NI 627.8m - CFO 673.1m) / TA 11.72b) |
| Beneish M-Score: -2.64 (Cap -4..+1) = A |
What is the price of SON shares?
Over the past week, the price has changed by +6.92%, over one month by +10.63%, over three months by +28.55% and over the past year by +12.89%.
Is SON a buy, sell or hold?
- StrongBuy: 5
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.8 | 4.7% |
| Analysts Target Price | 53.8 | 4.7% |
| ValueRay Target Price | 58.2 | 13.3% |
SON Fundamental Data Overview February 04, 2026
P/E Forward = 8.0386
P/S = 0.669
P/B = 1.4401
P/EG = 0.2027
Revenue TTM = 6.12b USD
EBIT TTM = 330.4m USD
EBITDA TTM = 817.2m USD
Long Term Debt = 3.79b USD (from longTermDebt, last quarter)
Short Term Debt = 1.37b USD (from shortTermDebt, last quarter)
Debt = 5.40b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.16b USD (from netDebt column, last quarter)
Enterprise Value = 9.92b USD (4.76b + Debt 5.40b - CCE 244.9m)
Interest Coverage Ratio = 1.43 (Ebit TTM 330.4m / Interest Expense TTM 231.8m)
EV/FCF = 33.23x (Enterprise Value 9.92b / FCF TTM 298.4m)
FCF Yield = 3.01% (FCF TTM 298.4m / Enterprise Value 9.92b)
FCF Margin = 4.88% (FCF TTM 298.4m / Revenue TTM 6.12b)
Net Margin = 10.26% (Net Income TTM 627.8m / Revenue TTM 6.12b)
Gross Margin = 21.46% ((Revenue TTM 6.12b - Cost of Revenue TTM 4.81b) / Revenue TTM)
Gross Margin QoQ = 21.93% (prev 21.27%)
Tobins Q-Ratio = 0.85 (Enterprise Value 9.92b / Total Assets 11.72b)
Interest Expense / Debt = 1.13% (Interest Expense 61.2m / Debt 5.40b)
Taxrate = 5.90% (7.72m / 130.8m)
NOPAT = 310.9m (EBIT 330.4m * (1 - 5.90%))
Current Ratio = 0.92 (Total Current Assets 3.16b / Total Current Liabilities 3.42b)
Debt / Equity = 1.63 (Debt 5.40b / totalStockholderEquity, last quarter 3.30b)
Debt / EBITDA = 6.31 (Net Debt 5.16b / EBITDA 817.2m)
Debt / FCF = 17.28 (Net Debt 5.16b / FCF TTM 298.4m)
Total Stockholder Equity = 2.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.05% (Net Income 627.8m / Total Assets 11.72b)
RoE = 22.30% (Net Income TTM 627.8m / Total Stockholder Equity 2.82b)
RoCE = 5.00% (EBIT 330.4m / Capital Employed (Equity 2.82b + L.T.Debt 3.79b))
RoIC = 3.45% (NOPAT 310.9m / Invested Capital 9.00b)
WACC = 4.44% (E(4.76b)/V(10.16b) * Re(8.27%) + D(5.40b)/V(10.16b) * Rd(1.13%) * (1-Tc(0.06)))
Discount Rate = 8.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.24%
[DCF Debug] Terminal Value 86.97% ; FCFF base≈308.7m ; Y1≈329.8m ; Y5≈398.5m
Fair Price DCF = 67.35 (EV 11.80b - Net Debt 5.16b = Equity 6.64b / Shares 98.6m; r=5.90% [WACC]; 5y FCF grow 7.63% → 2.90% )
EPS Correlation: 0.77 | EPS CAGR: 22.39% | SUE: -0.67 | # QB: 0
Revenue Correlation: -18.75 | Revenue CAGR: 11.05% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.26 | Chg30d=-0.020 | Revisions Net=-3 | Analysts=7
EPS next Year (2026-12-31): EPS=5.96 | Chg30d=-0.059 | Revisions Net=-6 | Growth EPS=+5.3% | Growth Revenue=-2.0%